| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523470A1 Novel compounds as histone deacetylase inhibitors |
| 04/20/2005 | EP1523338A1 Steroid conjugates, their preparation and the use thereof |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523318A2 Treatment of human multiple myeloma by curcumin |
| 04/20/2005 | EP1523313A1 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4- 1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
| 04/20/2005 | EP1453977A4 Molecular characteristics of non-small cell lung cancer |
| 04/20/2005 | EP1443921B1 Production of pure stereoisomers of tricyclo-[5.2.1.0(2.6)]-dec-9-yl-xanthate esters and their use as medicaments |
| 04/20/2005 | EP1383494A4 Compositions and methods for the prevention and treatment of human prostate cancer |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1320534B1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 04/20/2005 | EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 04/20/2005 | EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | EP1178810B1 Use of bisphosphonic acids for treating angiogenesis |
| 04/20/2005 | EP1177185B1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 04/20/2005 | EP1141326B1 Human akt-3 |
| 04/20/2005 | EP1140904B1 Farnesyl protein transferase inhibitors |
| 04/20/2005 | EP1135168B1 Peptides carrying substances across the blood brain barrier |
| 04/20/2005 | EP1076651B1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 04/20/2005 | EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 04/20/2005 | EP1015431B1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP0956303B1 Non-naturally occurring lipoprotein particle |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1608135A Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1608063A Indolinone derivatives |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608060A Diaryl 1, 2, 4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608059A Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1607962A Manufacture of polyglutamate-therapeutic agent conjugates |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607953A Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 04/20/2005 | CN1607254A Process for preparing bio- red selenium |
| 04/20/2005 | CN1607248A Multifunctional anticancer recombinant adenovirus |
| 04/20/2005 | CN1607247A Dendritic cell tumor vaccine and its preparation and use |
| 04/20/2005 | CN1607209A Poly thymosin-alpha 1, its composition, its preparation method and application |
| 04/20/2005 | CN1607204A Cyclophosphamide quaternary ammonium salt derivant and its synthesis and use |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1606992A Medicine for treating malignant tumor and its preparation method |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197960C Immortalized human kerationocyte cell line |
| 04/20/2005 | CN1197877C AsLc-IFN fusion protein and its preparation |
| 04/20/2005 | CN1197871C 5'-deoxy-cytidine derivatives |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197847C Compound N-total trans dimension methanamide derivative and its preparation method and application |
| 04/20/2005 | CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
| 04/20/2005 | CN1197619C Biological therapy adjuvant originated from animal Chinese medicine |
| 04/20/2005 | CN1197615C Antineoplastic medicine and its preparation process |
| 04/20/2005 | CN1197608C Medicine for treating esophageal cancer and gastric cancer and its preparation method |
| 04/20/2005 | CN1197577C Therapeutic use of 4-anilino quinazoline derivative in preparing drug for preventing breast cancer paroxysm |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881854 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 04/19/2005 | US6881846 Antiproliferative agents |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881822 Antibody for use in the treatment of tumors |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881751 Medicament containing platinum complex compounds and the use thereof |
| 04/19/2005 | US6881743 Pyridine matrix metalloproteinase inhibitors |
| 04/19/2005 | US6881737 Substituted triazinyl acrylamide derivatives and methods of use |
| 04/19/2005 | US6881731 Enhancers for microbiological disinfection |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 04/19/2005 | US6881405 Reagents and methods for inducing an immune response to prostate specific antigen |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/14/2005 | WO2005033301A1 Cell activation method and cell production method and medicinal composition using the same |
| 04/14/2005 | WO2005033141A1 Regulation of matrix metalloproteinases by psp94 family members |
| 04/14/2005 | WO2005033126A1 Cell surface marker |
| 04/14/2005 | WO2005033111A1 Dihydroporphine derivatives, processes for their preparation,and pharmaceutical compositions containing them |
| 04/14/2005 | WO2005033109A1 Triazinoindolamine compound |
| 04/14/2005 | WO2005033104A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033098A1 Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 04/14/2005 | WO2005033096A1 Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof |
| 04/14/2005 | WO2005033086A1 Compounds and compositions as protein kinase inhibitors |
| 04/14/2005 | WO2005033077A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 04/14/2005 | WO2005032568A1 Immunopotentiator, antiulcer agent and processed foods comprising fermented soybean product and process for producing fermented soybean product |
| 04/14/2005 | WO2005032548A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/14/2005 | WO2005032535A1 Nerve regeneration promoters |
| 04/14/2005 | WO2005032515A1 New use, pharmaceutical preparations as well as a process for their production |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005021510A3 Benzimidazole c-2 heterocycles as kinase inhibitors |
| 04/14/2005 | WO2005016859A3 Proteasome inhibitors and methods of using the same |
| 04/14/2005 | WO2005011734A3 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | WO2005000318A3 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 04/14/2005 | WO2004103374A3 Imatinib combinations for head and neck cancers |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2003084529A8 Low-pressure mercury vapor discharge lamp |